First-in-human study of CPL’116 – a dual JAK/ROCK inhibitor – in healthy subjects

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2025-04-01
DOI
https://doi.org/10.3389/fphar.2025.1583723
Citations
1
Primary Topic
Cytokine Signaling Pathways and Interactions
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

First-in-human study of CPL’116 – a dual JAK/ROCK inhibitor – in healthy subjects

Agnieszka Gierczak‐Pachulska, Piotr Pankiewicz, Daniel Rabczenko, Paweł Żero et al.
1 citations
Frontiers in Pharmacology
Cytokine Signaling Pathways and Interactions
1.05
article

First-in-human study of CPL’116 – a dual JAK/ROCK inhibitor – in healthy subjects

Agnieszka Gierczak‐Pachulska, Piotr Pankiewicz, Daniel Rabczenko, Paweł Żero, Michał Kaza, Dorota Włodarczyk, Katarzyna Jarus‐Dziedzic, Martyna Banach, Beata M. Zygmunt, Maciej Wieczorek, Agnieszka Segiet, Piotr J. Rudzki, Cezary Piwowarczyk
article en
1 citations

Abstract

No abstract available for this paper.
Frontiers in PharmacologyVol. 16
Institute of Physiology and Pathology of Hearing (PL), Celon Pharma (Poland) (PL)
Openalex Percentile: Top 24%
Cytokine Signaling Pathways and Interactions
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.